Home/Rivaroxaban Shows Superiority Over Aspirin in Patients With Coronary and Peripheral Artery Disease/Rivaroxaban Shows Superiority Over Aspirin in Patients With Coronary and Peripheral Artery Disease Rivaroxaban Shows Superiority Over Aspirin in Patients With Coronary and Peripheral Artery Disease